Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Figure 1. Atlanta High Intensity Drug Trafficking
Figure 2. Atlanta Metropolitan Area Transportation Infrastructure
Figure 3. North Carolina Counties in the Atlanta HIDTA Transportation Infrastructure
Table 1. Atlanta HIDTA
Drug Seizures, by Initiative, in Kilograms, 2009
Table 2. Cannabis Plants Eradicated at Outdoor and Indoor Grow Sites in Georgia and North Carolina, 2005-2009
Table 3. Primary/Secondary/Tertiary Substance Problem at Admission, Atlanta HIDTA Counties in Georgia, State Fiscal Year (SFY) 2007-2009
Table A1. Methamphetamine Laboratories Seized in Atlanta HIDTA Counties, 2005-2009
The principal drug threats to the Atlanta High Intensity Drug Trafficking Area (HIDTA) region are the distribution and abuse of cocaine and the production and abuse of methamphetamine. Controlled prescription drugs (CPDs) pose an emerging threat and heroin remains a relatively low but growing threat to the region. In addition, the Atlanta area is the principal bulk cash consolidation center for Mexican drug trafficking organizations (DTOs) operating in the eastern United States.
The following are significant strategic drug threat developments in the Atlanta HIDTA region:
To Top To Contents
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040
FAX (202) 514-4252
Questions and comments may be directed to Southeast/Florida/Caribbean Unit, Regional Threat Analysis Branch through NDIC.Contacts@usdoj.gov.
a. Opioid pain relievers include codeine, fentanyl (Duragesic, Actiq), hydromorphone (Dilaudid), meperidine (Demerol), morphine (MS Contin), oxycodone (OxyContin), methadone (Dolophine), and hydrocodone combinations (Vicodin, Lortab, and Lorcet).
End of page.